Ginkgo lands on Nasdaq via $17.5B SPAC merger, giving it billions to fuel growth

Ginkgo Bioworks is set to go public through a $17.5 billion merger with a special purpose acquisition company (SPAC). The deal, which involves Arie Belldegrun, will generate $2.5 billion of gross cash proceeds to support Ginkgo’s efforts to engineer cells to enable new product development.